AACR establishes award in honor of Dr. Von Hoff for his groundbreaking accomplishments as a dedicated and inspirational educator and for his sustained scientific innovationContinue reading
Category Archives: AZBio News
BIO Leads Group Challenging Administration’s “Most Favored Nation” Rule
On December 4, 2020, the Biotechnology Innovation Organization (BIO), the California Life Sciences Association (CLSA), and BIOCOM California today filed a challenge against the Department of Health and Human Services’ (HHS) attempt, during the final days of the Trump Administration, to implement for the first time ever a “Most Favored Nation” reimbursement policy for certain drugs administered by Medicare Part B providers – drastically altering this system in ways that will harm their ability to serve America’s most vulnerable senior citizens.Continue reading
C-Path, Ltd. Announces New Contract with Innovative Medicines Initiative
DUBLIN, Ireland, December 3, 2020 — Critical Path Institute, Ltd. (C-Path, Ltd.) announced today a new contract with the Innovative Medicines Initiative 2 Joint Undertaking (IMI2 JU). The new project will leverage C-Path’s global expertise in developing novel product development tools.Continue reading
Governor Ducey Announces Latest Actions To Fight COVID-19, Increase Hospital Staffing
Governor Ducey Announces Latest Actions To Fight COVID-19, Increase Hospital StaffingContinue reading
Applications open for fall 2021 cohort of new learning-by-doing master’s degree in innovation
Have you dreamed of starting your own business? Are you obsessed with the idea of making the world a better place? Are you impatient for progress? Do you have a great idea, but don’t know where to start?Continue reading
C-Path Quantitative Medicine Program Awarded FDA Contract to Develop Tools for Neuroscience Diseases
TUCSON, Ariz., December 2, 2020 — The Critical Path Institute (C-Path) today announced it has been awarded a U.S. Food and Drug Administration (FDA) contract in support of the development of open-source tools to improve the efficiency of trial design for three neuroscience diseases: Alzheimer’s disease (AD), Parkinson’s disease (PD) and Duchenne muscular dystrophy (DMD). C-Path’s Quantitative Medicine (QuantMed) Program will carry out the project through its work in collaboration with its three C-Path Public-Private Partnerships: the Critical Path for Alzheimer’s Disease (CPAD), the Critical Path for Parkinson’s (CPP) and the Duchenne Regulatory Science Consortium (D-RSC).Continue reading
AquaVitas, LLC Announces Contract from U.S. Government and Health and Human Services for Nationwide Testing of Wastewater for SARS-CoV-2
Award will fund a collaborative effort between AquaVitas, LLC, the Centers for Disease Control and Prevention and Health and Human Services to identify best practices for wastewater SARS- CoV-2 assessment and subsequent data analytics across the U.S.
Phase 1 award will fund assessment of wastewater at up to 100 treatment plants (representing ~10% of the U.S. population).
Optional Phase 2 award will scale to fund assessment of wastewater at up to 340 treatment plants (representing ~30% of the U.S. population in at least 42 states).Continue reading
Calviri Appoints Michael McCallister to Board of Directors
TEMPE, Ariz.–(BUSINESS WIRE)–Calviri, Inc. (www.calviri.com) announces today the appointment of Michael McCallister to the company’s Board of Directors. Mr. McCallister has a breadth of governance and management experience in multiple industries, including health insurance, financial services, and animal life sciences.Continue reading
GT Medical Technologies Announces $16 Million Financing to Expand Availability of Targeted Therapy for Patients with Recurrent Brain Tumors
GammaTile Therapy Offers Patients a Proven Option to Slow Brain Tumor Progression, Delay Recurrence and Avoid Additional Trips to the Hospital for Radiation TherapyContinue reading